American Vietnamese Biotech Incorporation (HNX:AMV)
1,700.00
-100.00 (-5.56%)
At close: Apr 28, 2026
HNX:AMV Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 222,880 | 262,211 | 196,658 | 511,312 | 432,649 | 1,311,968 | Upgrade
|
| Market Cap Growth | -56.41% | 33.33% | -61.54% | 18.18% | -67.02% | 63.02% | Upgrade
|
| Enterprise Value | 434,809 | 465,766 | 400,671 | 648,941 | 242,218 | 1,392,443 | Upgrade
|
| Last Close Price | 1700.00 | 2000.00 | 1500.00 | 3900.00 | 3300.00 | 13761.65 | Upgrade
|
| PE Ratio | - | - | - | 47.85 | 8.02 | 15.95 | Upgrade
|
| PS Ratio | 1.45 | 1.70 | 0.63 | 2.60 | 1.54 | 5.86 | Upgrade
|
| PB Ratio | 0.14 | 0.16 | 0.12 | 0.30 | 0.26 | 1.08 | Upgrade
|
| P/TBV Ratio | 0.15 | 0.18 | 0.13 | 0.33 | 0.28 | 1.18 | Upgrade
|
| P/FCF Ratio | 0.90 | 1.06 | 0.31 | - | - | - | Upgrade
|
| P/OCF Ratio | 0.86 | 1.01 | 0.29 | - | - | - | Upgrade
|
| EV/Sales Ratio | 2.82 | 3.02 | 1.29 | 3.30 | 0.86 | 6.22 | Upgrade
|
| EV/EBITDA Ratio | - | 87.43 | 33.35 | 11.95 | 2.89 | 12.05 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 19.99 | 3.82 | 13.97 | Upgrade
|
| EV/FCF Ratio | 1.76 | 1.89 | 0.64 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 28.09 | 28.09 | 12.87 | 3.07 | 2.03 | 1.58 | Upgrade
|
| Debt / FCF Ratio | 0.61 | 0.61 | 0.25 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.09 | 0.09 | 0.08 | 0.05 | 0.06 | 0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | 26.65 | 26.65 | 11.43 | 1.52 | 1.10 | 1.33 | Upgrade
|
| Net Debt / FCF Ratio | 0.58 | 0.58 | 0.22 | -0.57 | -0.27 | -0.30 | Upgrade
|
| Asset Turnover | 0.08 | 0.08 | 0.16 | 0.10 | 0.16 | 0.18 | Upgrade
|
| Inventory Turnover | 2.62 | 2.62 | 1.54 | 0.53 | 0.74 | 0.64 | Upgrade
|
| Quick Ratio | 3.03 | 3.03 | 2.03 | 1.57 | 1.73 | 1.01 | Upgrade
|
| Current Ratio | 4.19 | 4.19 | 6.10 | 9.93 | 8.13 | 6.40 | Upgrade
|
| Return on Equity (ROE) | -3.31% | -3.31% | -0.78% | 0.64% | 3.82% | 8.05% | Upgrade
|
| Return on Assets (ROA) | -0.89% | -0.89% | -0.14% | 1.02% | 2.25% | 5.11% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.57% | -1.54% | -0.24% | 1.72% | 3.95% | 9.03% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.60% | -1.60% | -0.20% | 1.80% | 3.50% | 7.30% | Upgrade
|
| Earnings Yield | -23.80% | -20.23% | -5.69% | 2.09% | 12.46% | 6.27% | Upgrade
|
| FCF Yield | 110.65% | 94.06% | 319.61% | -28.32% | -80.36% | -38.94% | Upgrade
|
| Payout Ratio | - | - | - | 8.19% | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.09% | 0.09% | - | -22.04% | -27.63% | -58.37% | Upgrade
|
| Total Shareholder Return | 0.09% | 0.09% | - | -22.04% | -27.63% | -58.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.